InvestorsHub Logo
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

Re: DanWebzster post# 25

Thursday, 03/01/2018 1:05:38 PM

Thursday, March 01, 2018 1:05:38 PM

Post# of 438
MESO

Reported exceptionally good results in Ph3 study treating steroid refractory GvHD.

Accelerated Approval is possible

Cash runway will only take it thru 2018

It may tap 90mn equity facility until partner is secured.

Seems intent on securing partner rather than diluting.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.